Belpointe Asset Management LLC Frequency Therapeutics, Inc. Transaction History

Belpointe Asset Management LLC

  • $1.28 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.44 - $5.47 $44 - $547
-100 Reduced 1.03%
9,575 $4,000
Q4 2022

Feb 08, 2023
BUY
$1.88 - $3.85 $18,189 - $37,248
9,675 New
9,675 $37,000

About Frequency Therapeutics, Inc.

FREQ Quotes by TradingView
  • Ticker FREQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,262,000
  • Description
  • Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...
More about FREQ
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email